Twist Bioscience Corp (TWST)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$159.28
Buy
$165.00
$7.73 (+5.08%)
Prices updated at 10 Oct 2026, 00:58 EDT
| Prices minimum 15 mins delay
Prices in USD
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company’s proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rat ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2024 | 2025 |
|---|---|---|
| 313m | 377m | |
| 133m | 191m | |
| -176m | -136m | |
| -56.20 | -36.18 | |
| -209m | -78m | |
| -144m | -111m | |
| Sales, General and administrative | 218m | 247m |
| Interest expenses | - | - |
| Provision for income taxes | 560,000 | 719,000 |
| Operating expenses | 309m | 327m |
| Income before taxes | -208m | -77m |
| Net income available to common shareholders | -209m | -78m |
| -3.6 | -1.3 | |
| Net interest income | 15m | 11m |
| Advertising and promotion | - | - |
| Net investment income, net | - | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | -3.6 | -1.3 |
| Free cash flow per share | -1.1923 | -1.2646 |
| Book value/share | 7.9334 | 7.7188 |
| Debt equity ratio | 0.148556 | 0.130561 |
Balance sheet
Year | 2024 | 2025 |
|---|---|---|
| Current assets | 347m | 333m |
| Current liabilities | 71m | 91m |
| Total capital | 473m | 473m |
| Total debt | 85m | 76m |
| Total equity | 473m | 473m |
| Total non current liabilities | - | - |
| Loans | - | - |
| Total assets | 614m | 642m |
| Total liabilities | - | - |
| Cash and cash equivalents | 226m | 183m |
| Common stock | 59m | 61m |
Cash flow
Year | 2024 | 2025 |
|---|---|---|
| Cash at beginning of period | 289m | 229m |
| Cash dividends paid | - | - |
| -69m | -76m | |
| Investments (gains) losses | -3m | -25m |
| 229m | 185m | |
| Net income | - | - |
| -64m | -48m | |
| -5m | -28m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.
